Ritesh Agrawal

Summary

Publications

  1. ncbi request reprint Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib
    Suresh Kumar
    Department of Chemistry, Shrimant Madhavrao Scindia, Government Model Science College, Jhansi Road, Gwalior, Madhya Pradesh, PIN No 474001, India
    Recent Pat Anticancer Drug Discov 9:382-93. 2014
  2. ncbi request reprint The first approved agent in the Glitazar's Class: Saroglitazar
    Ritesh Agrawal
    Department of Chemistry, Shrimant Madhavrao Scindia, Government Model Science College, Jhansi Road, Gwalior, Madhya Pradesh, PIN No 474001, India
    Curr Drug Targets 15:151-5. 2014
  3. ncbi request reprint 3D QSAR and docking studies of various amido and benzyl-substituted 3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl analogs as DPP-IV inhibitors
    Ritesh Agrawal
    Department of Chemistry, Shrimant Madhavrao Scindia, Government Model Science College, Jhansi Road, Gwalior, Madhya Pradesh, India, PIN No 474001
    Protein Pept Lett 20:1066-78. 2013
  4. ncbi request reprint 3D QSAR and docking study of gliptin derivatives as DPP-IV inhibitors
    Ritesh Agrawal
    Department of Chemistry, Shrimant Madhavrao Scindia, Government Model Science College, Jhansi Road, Gwalior, Madhya Pradesh, PIN No 474001, India
    Comb Chem High Throughput Screen 16:249-73. 2013
  5. ncbi request reprint Ligand-based pharmacophore detection, screening of potential gliptins and docking studies to get effective antidiabetic agents
    Ritesh Agrawal
    Department of Chemistry, Government Shrimant Madhavrao Scindia, Model Science College, Jhansi Road, Gwalior, Madhya Pradesh 474001, India
    Comb Chem High Throughput Screen 15:849-76. 2012
  6. ncbi request reprint Novel serine protease dipeptidyl peptidase IV inhibitor: alogliptin
    Ritesh Agrawal
    Department of Chemistry, Shrimant Madhavrao Scindia, Government Model Science College, Jhansi Road, Gwalior, Madhya Pradesh, India, PIN No 474001
    Mini Rev Med Chem 12:1345-58. 2012
  7. ncbi request reprint Linagliptin: a novel methylxanthin based approved dipeptidyl peptidase-4 inhibitor
    Ritesh Agrawal
    Department of Chemistry, Shrimant Madhavrao Scindia, Government Model Science College, Jhansi Road, Gwalior, Madhya Pradesh, PIN No 474001, India
    Curr Drug Targets 13:970-83. 2012
  8. ncbi request reprint Apixaban: a new player in the anticoagulant class
    Ritesh Agrawal
    Department of Chemistry, Shrimant Madhavrao Scindia, Government Model Science College, Jhansi Road, Gwalior, Madhya Pradesh, PIN No 474001, India
    Curr Drug Targets 13:863-75. 2012
  9. ncbi request reprint Oseltamivir: a first line defense against swine flu
    Ritesh Agrawal
    Poona College of Pharmacy, Bharati Vidyapeeth University, Pune 411 038 Maharashtra, India
    Med Chem 6:247-51. 2010
  10. ncbi request reprint Emphysematous gastritis causing gastric and esophageal necrosis in a young boy
    Nitin Agarwal
    Department of Surgery, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi l 10095, India
    Acta Gastroenterol Belg 72:354-6. 2009

Detail Information

Publications10

  1. ncbi request reprint Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib
    Suresh Kumar
    Department of Chemistry, Shrimant Madhavrao Scindia, Government Model Science College, Jhansi Road, Gwalior, Madhya Pradesh, PIN No 474001, India
    Recent Pat Anticancer Drug Discov 9:382-93. 2014
    ..In this review, we have summarized the chemical characterization of afatinib, its synthesis, patent status, marketed formulation, available crystalline form and current clinical trials. ..
  2. ncbi request reprint The first approved agent in the Glitazar's Class: Saroglitazar
    Ritesh Agrawal
    Department of Chemistry, Shrimant Madhavrao Scindia, Government Model Science College, Jhansi Road, Gwalior, Madhya Pradesh, PIN No 474001, India
    Curr Drug Targets 15:151-5. 2014
    ..Saroglitazar regulates the lipid parameters as well as glycemic control. The present article describes Saroglitazar with its chemical synthesis and patent status with its summary of clinical studies. ..
  3. ncbi request reprint 3D QSAR and docking studies of various amido and benzyl-substituted 3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl analogs as DPP-IV inhibitors
    Ritesh Agrawal
    Department of Chemistry, Shrimant Madhavrao Scindia, Government Model Science College, Jhansi Road, Gwalior, Madhya Pradesh, India, PIN No 474001
    Protein Pept Lett 20:1066-78. 2013
    ..This study provides a set of guidelines for designing compounds with better DPP-IV inhibitory potency. ..
  4. ncbi request reprint 3D QSAR and docking study of gliptin derivatives as DPP-IV inhibitors
    Ritesh Agrawal
    Department of Chemistry, Shrimant Madhavrao Scindia, Government Model Science College, Jhansi Road, Gwalior, Madhya Pradesh, PIN No 474001, India
    Comb Chem High Throughput Screen 16:249-73. 2013
    ..The findings of the QSAR study provide a set of guidelines for designing compounds with better DPP-IV inhibitory potency...
  5. ncbi request reprint Ligand-based pharmacophore detection, screening of potential gliptins and docking studies to get effective antidiabetic agents
    Ritesh Agrawal
    Department of Chemistry, Government Shrimant Madhavrao Scindia, Model Science College, Jhansi Road, Gwalior, Madhya Pradesh 474001, India
    Comb Chem High Throughput Screen 15:849-76. 2012
    ..In the present research work, we have covered rational of DPP-IV inhibitor based on Ligand-Based Pharmacophore detection, which is validated via the Docking interaction studies as well as Maximal Common Substructure (MCS)...
  6. ncbi request reprint Novel serine protease dipeptidyl peptidase IV inhibitor: alogliptin
    Ritesh Agrawal
    Department of Chemistry, Shrimant Madhavrao Scindia, Government Model Science College, Jhansi Road, Gwalior, Madhya Pradesh, India, PIN No 474001
    Mini Rev Med Chem 12:1345-58. 2012
    ....
  7. ncbi request reprint Linagliptin: a novel methylxanthin based approved dipeptidyl peptidase-4 inhibitor
    Ritesh Agrawal
    Department of Chemistry, Shrimant Madhavrao Scindia, Government Model Science College, Jhansi Road, Gwalior, Madhya Pradesh, PIN No 474001, India
    Curr Drug Targets 13:970-83. 2012
    ....
  8. ncbi request reprint Apixaban: a new player in the anticoagulant class
    Ritesh Agrawal
    Department of Chemistry, Shrimant Madhavrao Scindia, Government Model Science College, Jhansi Road, Gwalior, Madhya Pradesh, PIN No 474001, India
    Curr Drug Targets 13:863-75. 2012
    ....
  9. ncbi request reprint Oseltamivir: a first line defense against swine flu
    Ritesh Agrawal
    Poona College of Pharmacy, Bharati Vidyapeeth University, Pune 411 038 Maharashtra, India
    Med Chem 6:247-51. 2010
    ..In present review, we have tried to cover chemistry, mode of binding, total synthesis, current patent status, adverse effect and clinical status of Oseltamivir giving emphasis on medicinal chemistry aspect...
  10. ncbi request reprint Emphysematous gastritis causing gastric and esophageal necrosis in a young boy
    Nitin Agarwal
    Department of Surgery, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi l 10095, India
    Acta Gastroenterol Belg 72:354-6. 2009
    ..Emphysematous gastritis is rare in young patients without known risk factors. Also, only two previous cases have been reported with esophageal involvement. We have presented this case with a brief review of literature...